Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Broadening Immune System's Horizon For New HIV Defenses

Dec. 13, 2004

By Anette Breindl

Putting Nobel Prize-Winning Proteasome Research To Use

Dec. 10, 2004

By Anette Breindl

Putting Nobel Prize-Winning Proteasome Research To Use

Dec. 10, 2004

By Anette Breindl

Reduced Specificity Key To Fighting Gleevec Resistance?

Dec. 9, 2004

By Anette Breindl

Reduced Specificity Key To Fighting Gleevec Resistance?

Dec. 9, 2004

By Anette Breindl

For Once, Selective Pressure Leads To Nonfunctional Gene

Dec. 3, 2004

By Anette Breindl

For Once, Selective Pressure Leads To Nonfunctional Gene

Dec. 3, 2004

By Anette Breindl

Antimetastatic Antibodies In Immunological 'Fossil Record'

Dec. 1, 2004

By Anette Breindl

Antimetastatic Antibodies In Immunological 'Fossil Record'

Dec. 1, 2004

By Anette Breindl

View All Articles by Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 2, 2025
Ionis notches Arrowhead win; Tryngolza cleared for FCS
BioWorld
Ionis Pharmaceuticals Inc. CEO Brett Monia predicted that diagnoses of familial chylomicronemia syndrome (FCS) will “accelerate fairly quickly” now that the firm...
NRP1 is NGF/TrkA partner in crime in pain signaling
BioWorld Science
Chronic pain affects about 20% of the population worldwide. It is – inadequately – treated with nonsteroidal anti-inflammatory compounds and opioids that lack...
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.